Abiomed Acquires preCARDIA, a Breakthrough Medical Device Company, to Improve Outcomes for Heart Failure Patients
Abiomed (NASDAQ:ABMD) has acquired preCARDIA, developer of a proprietary catheter and controller that will complement Abiomed's product portfolio to expand options for patients with acute decompensated heart failure (ADHF). The preCARDIA system is uniquely designed to rapidly treat ADHF-related volume overload by effectively reducing cardiac filling pressures and promoting decongestion to improve overall cardiac and renal function.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210601005259/en/
Annually, more than one million patients are admitted to hospitals in the United States with ADHF. Despite available pharmaceutical treat
